1 Min Read
Oct 23 (Reuters) - PharmaLundensis AB:
* SAID ON MONDAY CO’S PATENT APPLICATION FOR IODOCARB COMP HAD BEEN APPROVED IN SAUDI ARABIA
Source text for Eikon:
Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.